TP53 and prostate cancer: Furthermore, in PC3 prostate cancer cells stably expressing p53, BI6727 likewise reduced p53 ubiquitination with little effect on overall ubiquitination levels (Figure 5C).Since BI6727 reduced p53 ubiquitination, we next investigated whether this effect was mediated by Topors.